Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation
Abstract
Inheritance of one defective copy of either of the two breast cancer susceptibility genes, BRCA1 and BRCA2, predisposes individuals to breast and ovarian cancers. Current progress in determining the function of these genes suggests that they participate in a common pathway to facilitate orderly homologous recombination and thereby maintain genomic integrity. As a consequence of this defect in homologous recombination, tumors that arise in BRCA carriers are likely to be more sensitive to ionizing radiation. This review summarizes recent investigations about the nature of the defect in DNA repair, and highlights the unanswered questions about the tumor suppressor paradox of BRCA genes. The unsolved mystery is the other genetic changes that must occur to turn a BRCA-deficient cell from a nonviable cell into a tumor cell capable of endless growth.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
BRCA gene mutation might influence response to radiation therapy because tumours in BRCA1/BRCA2 carriers are more sensitive to ionising radiation.
“Several studies suggest that BRCA gene mutation might influence response to radiation therapy because tumours in BRCA1/BRCA2 carriers are more sensitive to ionising radiation [5-12].”
From Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature (2010) · cites this paper as [11]
Cites
1 retracted
BRCA1 required for transcription-coupled repair of oxidative DNA damage
Gowen, L. C., Avrutskaya, A. V., Latour, A. M., Koller, B. H., & Leadon, S. A. (1998) · Science · doi:10.1126/science.281.5379.1009 · Cited by 496 · see citing works
RetractedA Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069 · see citing works
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645 · see citing works
Ford, D., Easton, D., Stratton, M. R., Narod, S., Goldgar, D., Devilee, P., Bishop, D., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · American Journal of Human Genetics · doi:10.1086/301749 · Cited by 2,766 · see citing works
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
Hall, J., Lee, M. K., Newman, B. M., Morrow, J. E., Anderson, L. A., Huey, B., & King, M. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,544 · see citing works
Risks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850 · cited 1× · see citing works
“In addition to the breast cancer risk, women with BRCA1 mutations have an increased risk of ovarian cancer (Ford et al., 1994).”
BackgroundKinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386761a0 · Cited by 1,240 · see citing works
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221 · see citing works
Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2
Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D., Regel, E., Dinh, C. Q., Sands, A., Gregor Eichele, C., Hasty, P., & Bradley, A. (1997) · Nature · doi:10.1038/386804a0 · Cited by 1,071 · see citing works
BRCA2 Is Required for Homology-Directed Repair of Chromosomal Breaks
Moynahan, M. E., Pierce, A. J., & Jasin, M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00174-5 · Cited by 1,007 · see citing works
Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.
Peto, J., Collins, N., Barfoot, R., Seal, S., Warren, W., Rahman, N., Easton, D., Evans, C., Deacon, J., & Stratton, M. R. (1999) · Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.943 · Cited by 909 · see citing works
Lakhani, S., van de Vijver, M., Jacquemier, J., Anderson, T., Osin, P., McGuffog, L., & Easton, D. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.023 · Cited by 888 · see citing works
Xu, X., Ohler, Z. W., Linke, S. P., Li, C., Gotay, J., Wang, X. W., Harris, C. C., Ried, T., & Deng, C. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80466-9 · Cited by 819 · see citing works
Xu, X., Wagner, K., Larson, D. M., Ohler, Z. W., Li, C., Ried, T., Hennighausen, L. G., Wynshaw-Boris, A. J., & Deng, C. (1999) · Nature Genetics · doi:10.1038/8743 · Cited by 758 · see citing works
Role of BRCA2 in Control of the RAD51 Recombination and DNA Repair Protein
Davies, A. A., Masson, J., McIlwraith, M. J., Stasiak, A. Z., Stasiak, A., Venkitaraman, A. R., & West, S. C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00175-7 · Cited by 720 · see citing works
Lakhani, S. R., Jacquemier, J., Sloane, J. P., Gusterson, B. A., Anderson, T. J., van de Vijver, M. J., Farid, L. M., Venter, D., Antoniou, A., Storfer-Isser, A., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.15.1138 · Cited by 707 · see citing works
BRCA2 Function in DNA Binding and Recombination from a BRCA2-DSS1-ssDNA Structure
Yang, H., Jeffrey, P. D., Miller, J. J., Kinnucan, E., Sun, Y., Thomä, N. H., Zheng, N., Chen, P., Lee, W., & Pavletich, N. P. (2002) · Science · doi:10.1126/science.297.5588.1837 · Cited by 705 · see citing works
Insights into DNA recombination from the structure of a RAD51–BRCA2 complex
Pellegrini, L., Yu, D. S., Lo, T., Anand, S., Lee, M., Blundell, T. L., & Venkitaraman, A. R. (2002) · Nature · doi:10.1038/nature01230 · Cited by 704 · see citing works
The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse.
Hakem, R., de la Pompa, J. L., Sirard, C., Mo, R., Woo, M., Hakem, A., Wakeham, A., Potter, J., Reitmair, A., Billia, F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81302-1 · Cited by 680 · see citing works
Chen, J., Silver, D. P., Walpita, D., Cantor, S. B., Gazdar, A. F., Tomlinson, G. E., Couch, F. J., Weber, B. L., Ashley, T., Livingston, D. M., et al. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80276-2 · Cited by 635 · see citing works
Involvement of Brca2 in DNA Repair
Patel, K. J., Yu, V. P. C. C., Lee, H., Corcoran, A. E., Thistlethwaite, F. C., Evans, M. J., Colledge, W. H., Friedman, L. S., Ponder, B. A. J., & Venkitaraman, A. R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80035-0 · Cited by 631 · see citing works
Association of BRCA1 with the hRad50-hMre11-p95 Complex and the DNA Damage Response
Zhong, Q., Chen, C.-F., Li, S., Chen, Y., Wang, C.-C., Xiao, J., Chen, P.-L., Sharp, Z. D., & Lee, W.-H. (1999) · Science · doi:10.1126/science.285.5428.747 · Cited by 626 · see citing works
Bhattacharyya, A., Ear, U., Koller, B. H., Weichselbaum, R. R., & Bishop, D. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000276200 · Cited by 584 · see citing works
Induction of GADD45 and JNK/SAPK-Dependent Apoptosis following Inducible Expression of BRCA1
Harkin, D. P., Bean, J. M., Miklos, D. B., Song, Y., Truong, V. B., Englert, C., Christians, F. C., Ellisen, L. W., Maheswaran, S., Oliner, J. D., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80769-2 · Cited by 558 · see citing works
Involvement of Brca1 in S-Phase and G 2 -Phase Checkpoints after Ionizing Irradiation
Xu, B., Kim, S., & Kastan, M. B. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3445-3450.2001 · Cited by 540 · see citing works
Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress
Tibbetts, R. S., Cortez, D., Brumbaugh, K. M., Scully, R., Livingston, D., Elledge, S. J., & Abraham, R. T. (2000) · Genes & Development · doi:10.1101/gad.851000 · Cited by 512 · see citing works
BRCA1 is a component of the RNA polymerase II holoenzyme
Scully, R., Anderson, S. F., Chao, D. M., Wei, W., Ye, L., Young, R. A., Livingston, D. M., & Parvin, J. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5605 · Cited by 454 · see citing works
Tutt, A. N. J., Bertwistle, D., Valentine, J., Gabriel, A., Swift, S., Ross, G., Griffin, C. S., Thacker, J., & Ashworth, A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4704 · Cited by 429 · see citing works
Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas
Wilson, C., Ramos, L., Villaseñor, M. R., Anders, K. H., Press, M. F., Clarke, K., Karlan, B. Y., Chen, J.-J., Scully, R., Livingston, D. M., et al. (1999) · Nature Genetics · doi:10.1038/6029 · Cited by 414 · see citing works
Chen, P., Chen, C., Chen, Y., Xiao, J., Sharp, Z. D., & Lee, W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5287 · Cited by 394 · see citing works
BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A
Anderson, S. F., Schlegel, B. P., Nakajima, T., Wolpin, E. S., & Parvin, J. D. (1998) · Nature Genetics · doi:10.1038/930 · Cited by 393 · see citing works
Genetic Analysis of BRCA1 Function in a Defined Tumor Cell Line
Scully, R., Ganesan, S., Vlasakova, K., Chen, J., Socolovsky, M., & Livingston, D. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80238-5 · Cited by 359 · see citing works
Yu, V. P. C. C., Koehler, M., Steinlein, C., Schmid, M., Hanakahi, L. A., van Gool, A. J., West, S. C., & Venkitaraman, A. R. (2000) · Genes & Development · doi:10.1101/gad.14.11.1400 · Cited by 321 · see citing works
Brca2 is required for embryonic cellular proliferation in the mouse.Preprint
Suzuki, A., de la Pompa, J. L., Hakem, R., Elia, A., Yoshida, R., Mo, R., Nishina, H., Chuang, T., Wakeham, A. C., Itié, A., et al. (1997) · Genes & Development · doi:10.1101/gad.11.10.1242 · Cited by 287 · see citing works
Paull, T. T., Cortez, D., Bowers, B., Elledge, S. J., & Gellert, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111125998 · Cited by 282 · see citing works
der Zwet, M. K.-V., Overkamp, W. J., van Lange, R. E. E., Essers, J., van Duijn-Goedhart, A., Wiggers, I., Swaminathan, S., van Buul, P. V., Errami, A., Tan, R., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.669-679.2002 · Cited by 267 · see citing works
Xia, F., Taghian, D. G., DeFrank, J. S., Zeng, Z., Willers, H., Iliakis, G. E., & Powell, S. N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151253498 · Cited by 263 · see citing works
Self-citationThe BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity
Baer, R. J. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00269-6 · Cited by 261 · see citing works
BRCA1 Effects on the Cell Cycle and the DNA Damage Response Are Linked to Altered Gene Expression
MacLachlan, T. K., Somasundaram, K., Sgagias, M. K., Shifman, Y., Muschel, R. J., Cowan, K. H., & El‐Deiry, W. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2777 · Cited by 212 · see citing works
Chen, C.-F., Chen, P.-L., Zhong, Q., Sharp, Z. D., & Lee, W.-H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32931 · Cited by 207 · see citing works
Snouwaert, J. N., Gowen, L. C., Latour, A. M., Mohn, A. R., Xiao, A., DiBiase, L., & Koller, B. H. (1999) · Oncogene · doi:10.1038/sj.onc.1203334 · Cited by 197 · see citing works
Li, S., Chen, P., Subramanian, T., Chinnadurai, G., Tomlinson, G. E., Osborne, C. K., Sharp, Z. D., & Lee, W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.11334 · Cited by 192 · see citing works
Gatei, M. H., Zhou, B. S., Hobson, K., Scott, S. P., Young, D., & Khanna, K. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011681200 · Cited by 189 · see citing works
Crook, T., Brooks, L. A., Crossland, S., Osin, P., Barker, K. T., Waller, J., Philp, E., Smith, P. D., Yuluğ, I. G., Peto, J., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1202106 · Cited by 179 · see citing works
p53 mutations in BRCA1-associated familial breast cancer
Crook, T., Crossland, S., Crompton, M. R., Osin, P., & Gusterson, B. A. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63327-2 · Cited by 179 · see citing works
Chromosomal Double-Strand Breaks Induce Gene Conversion at High Frequency in Mammalian Cells
Taghian, D. G., & Nickoloff, J. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6386 · Cited by 172 · see citing works
BRCA1 Facilitates Stress-induced Apoptosis in Breast and Ovarian Cancer Cell Lines
Thangaraju, M., Kaufmann, S. H., & Couch, F. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005824200 · Cited by 149 · see citing works
Marmorstein, L. Y., Kinev, A. V., Chan, G. K. T., Bochar, D. A., Beniya, H., Epstein, J. A., Yen, T. J., & Shiekhattar, R. (2001) · Cell · doi:10.1016/s0092-8674(01)00209-4 · Cited by 147 · see citing works
Environmental signals and cell fate specification in premigratory neural crest
Dorsky, R. I., Moon, R. T., & Raible, D. W. (2000) · BioEssays · doi:10.1002/1521-1878(200008)22:8 · Cited by 111 · see citing works
Coping with replication ‘train wrecks’ in Escherichia coli using Pol V, Pol II and RecA proteins
Goodman, M. F. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01564-4 · Cited by 107 · see citing works
The Expanding Role of Cell Cycle Regulators
Jacks, T., & Weinberg, R. A. (1998) · Science · doi:10.1126/science.280.5366.1035 · Cited by 103 · see citing works
Smith, P. D., Crossland, S., Parker, G. A., Osin, P., Brooks, L. A., Waller, J., Philp, E., Crompton, M. R., Gusterson, B. A., Allday, M. J., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202565 · Cited by 101 · see citing works
Haber, J. E., & Heyer, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00593-1 · Cited by 97 · see citing works
Developmental Studies of Brca1 and Brca2 Knock-Out Mice
Hakem, R., de la Pompa, J. L., & Mak, T. W. (1998) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018792200700 · Cited by 91 · see citing works
Activation of Transcription in Vitro by the BRCA1 Carboxyl-terminal Domain
Haile, D. T., & Parvin, J. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2113 · Cited by 81 · see citing works
Lehmann, A. R., Arlett, C. F., Burke, J. F., Green, M. H. L., James, M. R., & Lowe, J. E. (1985) · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · doi:10.1080/09553008514552881 · Cited by 67 · see citing works
BRCA1 signals ARF-dependent stabilization and coactivation of p53
Somasundaram, K., MacLachlan, T. K., Burns, T. F., Sgagias, M. K., Cowan, K. H., Weber, B. L., & El‐Deiry, W. S. (1999) · Oncogene · doi:10.1038/sj.onc.1203284 · Cited by 66 · see citing works
Schlegel, B. P., Green, V. J., Ladias, J. A. A., & Parvin, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3148 · Cited by 63 · see citing works
Powell, S. N., Willers, H., & Xia, F. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00789-x · Cited by 48 · see citing works
Self-citationBRCA1 and BRCA2 - breast cancer susceptibility genes
Hofmann, W., & Schlag, P. M. (2000) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320000140 · Cited by 43 · see citing works
Parvin, J. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121184998 · Cited by 36 · see citing works
The BRCA2 activation domain associates with and is phosphorylated by a cellular protein kinase
Milner, J., Fuks, F., Hughes‐Davies, L., & Kouzarides, T. (2000) · Oncogene · doi:10.1038/sj.onc.1203793 · Cited by 25 · see citing works
Independence of R/M/N Focus Formation and the Presence of Intact BRCA1
Wu, X., Petrini, J. H. J., Heine, W. F., Weaver, D. T., Livingston, D. M., & Chen, J. (2000) · Science · doi:10.1126/science.289.5476.11 · Cited by 22 · see citing works
Involvement ofBRCA1 andBRCA2 in breast cancer in a western Finnish sub-population
P��kk�nen, K., Sauramo, S., Sarantaus, L., Vahteristo, P., Hartikainen, A., Vehmanen, P., Ignatius, J., Ollikainen, V., K��ri�inen, H., Vauramo, E., et al. (2001) · Genetic Epidemiology · doi:10.1002/1098-2272(200102)20:2 · Cited by 11 · see citing works
Flagged first, then by citations
1 of the 65 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Hypoxia, DNA repair and genetic instability
Bristow, R. G., & Hill, R. P. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2344 · Cited by 1,140 · see citing works
Role of cell cycle in mediating sensitivity to radiotherapy
Pawlik, T. M., & Keyomarsi, K. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.03.005 · Cited by 1,101 · see citing works
Murr, R., Loizou, J. I., Yang, Y.-G., Cuenin, C., Li, H., Wang, Z.-Q., & Herceg, Z. (2006) · Nature Cell Biology · doi:10.1038/ncb1343 · Cited by 613 · see citing works
Ionizing Radiation-Induced DNA Damage, Response, and Repair
Santivasi, W. L., & Xia, F. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5668 · Cited by 603 · see citing works
Orth, M., Metzger, P., Gerum, S., Mayerle, J. V., Schneider, G., Belka, C., Schnurr, M., & Lauber, K. (2019) · Radiation Oncology · doi:10.1186/s13014-019-1345-6 · Cited by 488 · see citing works
DNA damage-induced activation of ATM and ATM-dependent signaling pathways
Kurz, E. U., & Lees‐Miller, S. P. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.03.029 · Cited by 478 · see citing works
Role of non-homologous end joining (NHEJ) in maintaining genomic integrity
Burma, S., Chen, B. P. C., & Chen, D. J. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.05.026 · Cited by 423 · see citing works
GUARDIN is a p53-responsive long non-coding RNA that is essential for genomic stability
Hu, W. L., Jin, L., Xu, A., Wang, Y. F., Thorne, R. F., Zhang, X. D., & Wu, M. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0066-7 · Cited by 348 · see citing works
Chan, N. H. L., Koritzinsky, M., Zhao, H. W., Bindra, R. S., Glazer, P. M., Powell, S. N., Belmaaza, A., Wouters, B. G., & Bristow, R. G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5472 · Cited by 328 · see citing works
Self-citationBreast Cancer Screening for Women at Higher-Than-Average Risk: Updated Recommendations From the ACR
Monticciolo, D. L., Newell, M. S., Moy, L. P., Lee, C. S., & Destounis, S. V. (2023) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2023.04.002 · Cited by 297 · see citing works
Splice variants as cancer biomarkers
Brinkman, B. M. N. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.05.015 · Cited by 265 · see citing works
Clapperton, J. A., Manke, I. A., Lowery, D. M., Ho, T., Haire, L. F., Yaffe, M. B., & Smerdon, S. J. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb775 · Cited by 243 · see citing works
Biomarkers of platinum resistance in ovarian cancer: what can we use to improve treatment
van Zyl, B., Tang, D., & Bowden, N. A. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0336 · Cited by 228 · see citing works
Pijpe, A., Andrieu, N., Easton, D., Kesminiene, A., Cardis, E., Noguès, C., Gauthier‐Villars, M., Lasset, C., Fricker, J., Peock, S., et al. (2012) · BMJ · doi:10.1136/bmj.e5660 · Cited by 228 · see citing works
Samstein, R. M., Krishna, C., Ma, X., Pei, X., Lee, K.-W., Makarov, V., Kuo, F., Chung, J., Srivastava, R. M., Purohit, T. A., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-00139-8 · Cited by 219 · see citing works
Self-citationCrypt Base Columnar Stem Cells in Small Intestines of Mice Are Radioresistant
Hua, G., Thin, T. H., Feldman, R., Haimovitz‐Friedman, A., Clevers, H. C., FUKS, Z. Y., & Kolesnick, R. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.106 · Cited by 206 · see citing works
Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302
Meng, F., Evans, J., Bhupathi, D., Banica, M., Lan, L., Lorente, G., Duan, J.-X., Cai, X., Mowday, A. M., Guise, C. P., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0634 · Cited by 205 · see citing works
The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications
Honrado, E., Benitez, J. J., & Palacios, J. (2005) · Modern Pathology · doi:10.1038/modpathol.3800453 · Cited by 190 · see citing works
The biology of DHX9 and its potential as a therapeutic target
Lee, T., & Pelletier, J. (2016) · Oncotarget · doi:10.18632/oncotarget.8446 · Cited by 190 · see citing works
Andrieu, N., Easton, D. F., Chang-Claude, J. C., Rookus, M. A., Brohet, R. M., Cardis, E., Antoniou, A. C., Wagner, T. M. U., Simard, J., Evans, D. G., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.3126 · Cited by 188 · see citing works
DNA damage response – A double-edged sword in cancer prevention and cancer therapy
Tian, H., Gao, Z., Li, H., Zhang, B., Wang, G., Zhang, Q., Pei, D., & Zheng, J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.038 · Cited by 186 · see citing works
Hereditary Prostate Cancer: Genes Related, Target Therapy and Prevention
Vietri, M. T., D’Elia, G., Caliendo, G., Resse, M., Casamassimi, A., Passariello, L., Albanese, L., Cioffi, M., & Molinari, A. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073753 · Cited by 171 · see citing works
Role of BRCA Mutations in the Modulation of Response to Platinum Therapy
Mylavarapu, S., Das, A., & Roy, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00016 · Cited by 172 · see citing works
Dauer, L. T., Brooks, A. L., Hoel, D. G., Morgan, W. F., Stram, D. O., & Tran, P. (2010) · Radiation Protection Dosimetry · doi:10.1093/rpd/ncq141 · Cited by 160 · see citing works
Poly(ADP-Ribose) Polymerase Inhibition: “Targeted” Therapy for Triple-Negative Breast Cancer
Anders, C. K., Winer, E. P., Ford, J. M., Dent, R. A., Silver, D. P., Sledge, G. W., & Carey, L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0939 · Cited by 154 · see citing works
Repair of radiation damage to DNA
Willers, H., Dahm‐Daphi, J., & Powell, S. N. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601729 · Cited by 152 · see citing works
Self-citationEpigenetic changes and nontargeted radiation effects—Is there a link?
Kovalchuk, O., & Baulch, J. E. (2008) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20361 · Cited by 144 · see citing works
ATM regulates target switching to escalating doses of radiation in the intestines
Ch'ang, H.-J., Maj, J. G., Paris, F., Xing, H. R., Zhang, J. J., Truman, J., Cardon‐Cardo, C., Haimovitz‐Friedman, A., Kolesnick, R., & FUKS, Z. Y. (2005) · Nature Medicine · doi:10.1038/nm1237 · Cited by 139 · see citing works
Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management
Kleibl, Z., & Kristensen, V. N. (2016) · The Breast · doi:10.1016/j.breast.2016.05.006 · Cited by 137 · see citing works
BRCA2 BRC motifs bind RAD51–DNA filaments
Galkin, V. E., Esashi, F., Yu, X., Yang, S., West, S. C., & Egelman, E. H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407266102 · Cited by 139 · see citing works
The interplay between DNA repair and autophagy in cancer therapy
Zhang, D., Tang, B., Xie, X., Xiao, Y., Yang, S., & Zhang, J. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1046022 · Cited by 131 · see citing works
Kirova, Y. M., Stoppa-Lyonnet, D., Savignoni, A., Sigal-Zafrani, B., Fabre, N., & Fourquet, A. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.02.037 · Cited by 129 · see citing works
Yin, L., Liu, Y., Peng, Y., Peng, Y., Yu, X., Gao, Y., Yuan, B., Zhu, Q., Cao, T., He, L., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0810-7 · Cited by 127 · see citing works
Bau, D., Fu, Y., Chen, S.-T., Cheng, T., Yu, J.-C., Wu, P.-E., & Shen, C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0403 · Cited by 126 · see citing works
Choudhury, A. D., Xu, H., & Baer, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403646200 · Cited by 123 · see citing works
Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis
Fernández-Madrid, F. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.12.017 · Cited by 120 · see citing works
Inhibitors of PARP: Number crunching and structure gazing
Rudolph, J., Jung, K., & Luger, K. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121979119 · Cited by 118 · see citing works
Phi, X.-A., Saadatmand, S., de Bock, G. H., Warner, E., Sardanelli, F., Leach, M. O., Riedl, C. C., Trop, I., Hooning, M. J., Mandel, R., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.32 · Cited by 116 · see citing works
Assembly of checkpoint and repair machineries at DNA damage sites
Huen, M. S. Y., & Chen, J. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.09.001 · Cited by 116 · see citing works
Willers, H., Taghian, A. G., Luo, C., Treszezamsky, A. D., Sgroi, D. C., & Powell, S. N. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0149 · Cited by 110 · see citing works
Self-citationTreszezamsky, A. D., Kachnic, L. A., Feng, Z., Zhang, J., Tokadjian, C., & Powell, S. N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0601 · Cited by 109 · see citing works
Self-citationPlumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo
Sinha, S., Pal, K., Elkhanany, A. M., Dutta, S. K., Cao, Y., Mondal, G., Iyer, S. R., Somasundaram, V., Couch, F. J., Shridhar, V., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27724 · Cited by 108 · see citing works
Campos, A., & Clemente‐Blanco, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020446 · Cited by 106 · see citing works
Minding the gap: The underground functions of BRCA1 and BRCA2 at stalled replication forks
Nagaraju, G., & Scully, R. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.02.020 · Cited by 103 · see citing works
Kirova, Y. M., Savignoni, A., Sigal-Zafrani, B., de La Rochefordiere, A., Salmon, R. J., This, P., Asselain, B., Stoppa-Lyonnet, D., & Fourquet, A. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0685-6 · Cited by 102 · see citing works
The evolution of meiosis: Recruitment and modification of somatic DNA-repair proteins
Marcon, E., & Møens, P. B. (2005) · BioEssays · doi:10.1002/bies.20264 · Cited by 103 · see citing works
Inhibition of ATR Leads to Increased Sensitivity to Hypoxia/Reoxygenation
Hammond, E. M., Dorie, M. J., & Giaccia, A. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1520 · Cited by 101 · see citing works
Liu, Q., Ma, L., Jones, T., Palomero, L., Pujana, M. Á., Martinez‐Ruiz, H., Ha, P. K., Murnane, J. P., Cuartas, I., Seoane, J., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1346 · Cited by 99 · see citing works
The mTOR Inhibitor Rapamycin Suppresses DNA Double-Strand Break Repair
Chen, H., Ma, Z., Vanderwaal, R. P., Feng, Z., González-Suárez, I., Wang, S., Zhang, J., Roti, J. L. R., Gonzalo, S., & Zhang, J. (2010) · Radiation Research · doi:10.1667/rr2323.1 · Cited by 97 · see citing works
The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy
Li, M., & Yu, X. (2014) · Oncogene · doi:10.1038/onc.2014.295 · Cited by 96 · see citing works
Gravells, P., Grant, E. K., Smith, K. M., James, D. I., & Bryant, H. E. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.02.010 · Cited by 96 · see citing works
Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer
Agalliu, I., Karlins, E., Kwon, E. M., Iwasaki, L. M., Diamond, A. G., Ostrander, E. A., & Stanford, J. L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603929 · Cited by 95 · see citing works
Sobeck, A., Stone, S., Costanzo, V., de Graaf, B., Reuter, T., de Winter, J. P., Wallisch, M., Akkari, Y. M. N., Olson, S. B., Wang, W., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.26.2.425-437.2006 · Cited by 92 · see citing works
Attenuated DNA Damage Repair by Trichostatin A through BRCA1 Suppression
Zhang, Y., Carr, T., Dimtchev, A., Zaer, N., Dritschilo, A., & Jung, M. (2007) · Radiation Research · doi:10.1667/rr0811.1 · Cited by 93 · see citing works
BET proteins: Biological functions and therapeutic interventions
Guo, J., Zheng, Q., & Peng, Y. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108354 · Cited by 91 · see citing works
Epigenetics in radiation biology: a new research frontier
Merrifield, M., & Kovalchuk, O. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00040 · Cited by 91 · see citing works
DNA Lesions Induced by Replication Stress Trigger Mitotic Aberration and Tetraploidy Development
Ichijima, Y., Yoshioka, K., Yoshioka, Y., Shinohe, K., Fujimori, H., Unno, J., Takagi, M., Goto, H., Inagaki, M., Mizutani, S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008821 · Cited by 79 · see citing works
BRCA1 tumor suppressor network: focusing on its tail
Wang, B. (2012) · Cell & Bioscience · doi:10.1186/2045-3701-2-6 · Cited by 78 · see citing works
Imaging and Oncologic Drug Development
El‐Deiry, W. S., Sigman, C. C., & Kelloff, G. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.5623 · Cited by 78 · see citing works
Good Timing in the Cell Cycle for Precise DNA Repair by BRCA1
Durant, S. T., & Nickoloff, J. A. (2005) · Cell Cycle · doi:10.4161/cc.4.9.2027 · Cited by 77 · see citing works
Antonova, L., & Mueller, C. R. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20538 · Cited by 75 · see citing works
Breast cancer intratumor genetic heterogeneity: causes and implications
Ng, C. K. Y., Pemberton, H. N., & Reis-Filho, J. S. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.12.85 · Cited by 74 · see citing works
Attardi, L. D. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.04.019 · Cited by 73 · see citing works
The S phase checkpoint: When the crowd meets at the fork
Gottifredi, V., & Prives, C. L. (2005) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2005.02.011 · Cited by 68 · see citing works
Evans, J., Chernikova, S. B., Kachnic, L. A., Banáth, J. P., Sordet, O., Delahoussaye, Y. M., Treszezamsky, A. D., Chon, B. H., Feng, Z., Gu, Y., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-06-4497 · Cited by 68 · see citing works
Self-citationThe Rad51/RadA N-Terminal Domain Activates Nucleoprotein Filament ATPase Activity
Galkin, V. E., Wu, Y., Zhang, X., Qian, X., He, Y., Yu, X., Heyer, W., Luo, Y., & Egelman, E. H. (2006) · Structure · doi:10.1016/j.str.2006.04.001 · Cited by 67 · see citing works
Association of abnormal morphology and altered gene expression in human preimplantation embryos
Wells, D., García-Bermúdez, M., Steuerwald, N., Malter, H. E., Thornhill, A. R., & Cohen, J. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.01.143 · Cited by 67 · see citing works
Tumor Cells Require Thymidylate Kinase to Prevent dUTP Incorporation during DNA Repair
Hu, C.-M., Yeh, M.-T., Tsao, N., Chen, C., Gao, Q.-Z., Chang, C.-Y., Lee, M.-H., Fang, J., Sheu, S., Lin, C.-J., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.038 · Cited by 65 · see citing works
Effect of Mammography on Breast Cancer Risk in Women with Mutations in BRCA1 or BRCA2
Goldfrank, D. J., Chuai, S., Bernstein, J. L., y Cajal, T. R., Lee, J. B., Alonso, M. C., Dı́ez, O., Baiget, M., Kauff, N. D., Offit, K., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0176 · Cited by 64 · see citing works
A Decade of Advances in Treatment for Advanced Non–Small Cell Lung Cancer
Gettinger, S. N., & Lynch, T. J. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.08.017 · Cited by 63 · see citing works
C-terminal binding proteins: Emerging roles in cell survival and tumorigenesis
Bergman, L., & Blaydes, J. P. (2006) · APOPTOSIS · doi:10.1007/s10495-006-6651-4 · Cited by 62 · see citing works
The ?portrait? of hereditary breast cancer
Lacroix, M., & Leclercq, G. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-2172-4 · Cited by 62 · see citing works
Hereditary breast cancer: From molecular pathology to tailored therapies
Tan, D. S. P., Marchiò, C., & Reis-Filho, J. S. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.057950 · Cited by 60 · see citing works
PRMT2 and RORγ Expression Are Associated With Breast Cancer Survival Outcomes
Oh, T. G., Bailey, P. J., Dray, E. V., Smith, A. G., Goode, J. M., Eriksson, N. A., Funder, J. W., Fuller, P. J., Simpson, E. R., Tilley, W. D., et al. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1403 · Cited by 60 · see citing works
Presynaptic filament dynamics in homologous recombination and DNA repair
Liu, J., Ehmsen, K. T., Heyer, W., & Morrical, S. W. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2011.576007 · Cited by 59 · see citing works
Histone acetylation dynamics in repair of DNA double-strand breaks
Aricthota, S., Rana, P. P., & Haldar, D. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.926577 · Cited by 59 · see citing works
Fridlich, R., Annamalai, D., Roy, R., Bernheim, G., & Powell, S. N. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.03.002 · Cited by 59 · see citing works
Self-citationFreedman, M. L., Penney, K. L., Stram, D. O., Marchand, L. L., Hirschhorn, J. N., Kolonel, L. N., Altshuler, D., Henderson, B. E., & Haiman, C. A. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh270 · Cited by 59 · see citing works
Hay, T., Jenkins, H., Sansom, O. J., Martin, N. M. B., Smith, G. C. M., & Clarke, A. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1186 · Cited by 59 · see citing works
Tumor oxygenation and cancer therapy—then and now
Hughes, V. S., Wiggins, J. M., & Siemann, D. W. (2018) · British Journal of Radiology · doi:10.1259/bjr.20170955 · Cited by 59 · see citing works
Zheng, C., Wei, Y., Zhang, Q., Sun, M., Wang, Y., Hou, J., Zhang, P., Lv, X., Su, D., Jiang, Y., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf3984 · Cited by 57 · see citing works
Emerging Multifunctional Carbon‐Nanomaterial‐Based Biosensors for Cancer Diagnosis
Britto, J. S. J., Guan, X., Tran, T. K. A., Lei, Z., Bahadur, R., Patel, V., Zhang, X., Wong, S. L., & Vinu, A. (2024) · Small Science · doi:10.1002/smsc.202300221 · Cited by 57 · see citing works
Wu-Baer, F., Ludwig, T., & Baer, R. J. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01056-09 · Cited by 57 · see citing works
Colin, C., Devic, C., Noël, A., Rabilloud, M., Zabot, M. T., Isaac, S., Giraud, S., Riche, B., Valette, P., Rodriguez‐Lafrasse, C., et al. (2011) · International Journal of Radiation Biology · doi:10.3109/09553002.2011.608410 · Cited by 57 · see citing works
Saccharomyces cerevisiae as a Model System To Define the Chromosomal Instability Phenotype
Putnam, C. D., Pennaneach, V., & Kolodner, R. D. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.7226-7238.2005 · Cited by 55 · see citing works
Recombination rate plasticity: revealing mechanisms by design
Stevison, L. S., Sefick, S. A., Rushton, C., & Graze, R. M. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0459 · Cited by 53 · see citing works
Şahin, İ. H., Lowery, M. A., Stadler, Z. K., Salo‐Mullen, E. E., Iacobuzio–Donahue, C. A., Kelsen, D. P., & O'Reilly, E. M. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1153424 · Cited by 52 · see citing works
The genetic prediction of risk for gynecologic cancers
Randall, L. M., & Pothuri, B. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.03.007 · Cited by 51 · see citing works
Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
Warner, E. (2018) · Cancers · doi:10.3390/cancers10120477 · Cited by 51 · see citing works
DNA Double-Strand Breaks as Pathogenic Lesions in Neurological Disorders
Provasek, V. E., Mitra, J., Malojirao, V. H., & Hegde, M. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094653 · Cited by 51 · see citing works
Wang, Q. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.89 · Cited by 51 · see citing works
O’Rorke, M. A., Murray, L., Brand, J. S., & Bhoo‐Pathy, N. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.05.001 · Cited by 48 · see citing works
Regulating BRCA1 protein stability by cathepsin S-mediated ubiquitin degradation
Kim, S., Jin, H. K., Seo, H. R., Lee, H. J., & Lee, Y. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0153-0 · Cited by 46 · see citing works
Liao, G., Huang, J., Fixman, E. D., & Hayward, S. D. (2004) · Journal of Virology · doi:10.1128/jvi.79.1.245-256.2005 · Cited by 46 · see citing works
Gastric Cancer Risk and Pathogenesis in BRCA1 and BRCA2 Carriers
Buckley, K. H., Niccum, B. A., Maxwell, K. N., & Katona, B. (2022) · Cancers · doi:10.3390/cancers14235953 · Cited by 41 · see citing works
Dss1 Interaction with Brh2 as a Regulatory Mechanism for Recombinational Repair
Zhou, Q., Kojić, M., Cao, Z., Lisby, M., Mazloum, N. A., & Holloman, W. K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01907-06 · Cited by 45 · see citing works
Misrepair in Context: TGFβ Regulation of DNA Repair
Liu, Q., Lopez, K. A. P., Murnane, J. P., Humphrey, T. C., & Barcellos‐Hoff, M. H. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00799 · Cited by 45 · see citing works
Roles of BCCIP in chromosome stability and cytokinesis
Meng, X., Fan, J., & Shen, Z. (2007) · Oncogene · doi:10.1038/sj.onc.1210460 · Cited by 45 · see citing works
Inhibition of PKM2 Enhances Sensitivity of Olaparib to Ovarian Cancer Cells and Induces DNA Damage
Zhou, S., Li, D., Xiao, D., Wu, T., Hu, X., Zhang, Y., Deng, J., Long, J., Xu, S., Wu, J., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.62947 · Cited by 43 · see citing works
DNA Damage Response and Repair: Insights Into Strategies for Radiation Sensitization of Gliomas
Kesari, S., Advani, S. J., Lawson, J. D., Kahle, K. T., Ng, K., Carter, B. S., & Chen, C. C. (2011) · Future Oncology · doi:10.2217/fon.11.111 · Cited by 40 · see citing works
- Authors
- Powell, S. N., & Kachnic, L. A.
- Affiliations
- Massachusetts General Hospital (US)
- Boston Medical Center (US)
- Corresponding author
- Powell, Simon N
- Venue
- Oncogene
- Published
- 2003-08-28
- Volume
- 22
- Issue
- 37
- Pages
- 5784-5791
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2115808409
- Cited by
- 364
- References
- 65
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 11 · 2023: 14 · 2022: 29 · 2021: 17 · 2020: 21 · 2019: 14 · 2018: 23 · 2017: 17 · 2016: 19 · 2015: 12 · 2014: 12 · 2013: 20 · 2012: 14
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- BRCA1, BRCA2, homologous recombination, DNA replication fidelity, radiosensitivity, DNA repair, genome stability, breast cancer susceptibility, ovarian cancer susceptibility, tumor initiation
- MeSH terms
- DNA Replication, Humans, Neoplasms, Radiation, Ionizing, Recombination, Genetic, Apoptosis, Genes, BRCA1, Genes, BRCA2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review